(Q37144104)

18 August 2017

1 reference

title

Genomic analysis of epithelial ovarian cancer (English)

1 reference

18 August 2017

1 reference

John Farley

1

1 reference

18 August 2017

Laurent L Ozbun

series ordinal

2

1 reference

18 August 2017

Michael J Birrer

series ordinal

3

1 reference

18 August 2017

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

18

1 reference

18 August 2017

538-548

1 reference

18 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2008.52

18 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Diagnosis and management of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Precursor lesions of ovarian epithelial malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Pathology of ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Ovarian clear cell adenocarcinoma: a continuing enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Etiology and pathogenesis of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

A candidate precursor to serous carcinoma that originates in the distal fallopian tube.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Incessant ovulation--a factor in ovarian neoplasia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

"Incessant ovulation" and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair/survival and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Assisted reproduction in patients with early-stage ovarian malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Genomic approaches to the pathogenesis of hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

The transcriptional program in the response of human fibroblasts to serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Genomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Genomics and proteomics: emerging technologies in clinical cancer research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

A distinct molecular profile associated with mucinous epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Modulation of paclitaxel resistance by annexin IV in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Gene expression profiling of human ovarian tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Gene expression profiling of epithelial ovarian tumours correlated with malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2008.52

Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis

21 January 2018

1 reference

12 December 2020

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas

1 reference

12 December 2020

Clinical characteristics and prognosis of mucinous tumors of the ovary

1 reference

12 December 2020

Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer

1 reference

12 December 2020

Aneuploidy and telomere attrition are independent determinants of crisis in SV40-transformed epithelial cells

1 reference

12 December 2020

Borderline Ovarian Tumor Workshop, Bethesda, Maryland, August 27-28, 2003

1 reference

12 December 2020

Ovarian cancer: the neglected diagnosis

1 reference

12 December 2020

Recurrent ovarian cancer.

1 reference

12 December 2020

Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone

1 reference

12 December 2020

Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens fromBRCA1 heterozygotes

2 references

12 December 2020

https://api.crossref.org/works/10.1038%2FCR.2008.52

7 January 2021

inferred from DOI database lookup

The biology of ovarian cancer development.

1 reference

12 December 2020

Androgens and ovarian cancers.

1 reference

12 December 2020

Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies

1 reference

12 December 2020

Endogenous hormones and ovarian cancer: epidemiology and current hypotheses.

1 reference

12 December 2020

Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease

1 reference

12 December 2020

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance

1 reference

12 December 2020

Surface cells and inclusion cysts in fetal ovaries

1 reference

12 December 2020

The distal fallopian tube: a new model for pelvic serous carcinogenesis.

1 reference

12 December 2020

Spontaneous transformation of rat ovarian surface epithelial cells results in well to poorly differentiated tumors with a parallel range of cytogenetic complexity

1 reference

12 December 2020

Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas

1 reference

12 December 2020

Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/CR.2008.52

1 reference

Dimensions Publication ID

18 August 2017

1029376220

0 references

Fatcat ID

release_z2ekxqytqncr7lpx42lyajueme

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/z2ekxqytqncr7lpx42lyajueme

24 November 2022

mapped directly with Wikidata item

1 reference